These observations suggest that T cell clones specific for CML may indeed by reactivated in vivo, in a similar manner to how ex vivo IL-2 treatment of T cells induces escape from anergy [88]. The gene discussed is IL2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.